Status:
COMPLETED
Assessing the Link Between Smoke Carcinogen Biomarkers and Lung Cancer Risk - 1
Lead Sponsor:
University of Minnesota
Collaborating Sponsors:
National Institute on Drug Abuse (NIDA)
Conditions:
Tobacco Use Disorder
Lung Cancer
Eligibility:
All Genders
55-74 years
Brief Summary
Lung cancer is the leading cause of cancer death in the United States. Currently it remains impossible to predict which smokers will get cancer. Each puff of a cigarette delivers a mixture of over 60 ...
Detailed Description
Lung cancer is the leading cause of cancer death in the United States. Approximately 90% of lung cancer is caused by cigarette smoking. While most lung cancer cases occur in smokers or ex-smokers, onl...
Eligibility Criteria
Inclusion
- Screening arm participants in the Prostate, Lung, Colon, and Ovarian Screen Trial (PLCO)
- Reported smoking on baseline questionnaire of PLCO
- Contributed biorepository samples
Exclusion
- Unstable physical or mental health
Key Trial Info
Start Date :
September 1 2005
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2007
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT00218179
Start Date
September 1 2005
End Date
December 1 2007
Last Update
January 23 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Minnesota
Minneapolis, Minnesota, United States, 55455